After intraperitoneal injection of JZL184 for 5 days a week over 5 weeks, dramatically decreased dopamine active transporter (DAT) and tyrosine hydroxylase (TH) expression in the PD animal was partially but significantly reversed. This evidence concerns the gene TH and Parkinson disease.